Teladoc (TDOC, Financial) has experienced a notable uptick in bullish sentiment, as evidenced by the trading of 7,777 call options, surpassing expectations by 10%. This activity is accompanied by a rise in implied volatility, which has climbed nearly 7 points to reach 67.94%. The most actively traded options are the May 2nd weekly 7 calls and the May 9th weekly 8 calls, with combined volumes reaching approximately 1,800 contracts, showcasing a strong investor interest at these strike prices.
The current Put/Call Ratio for TDOC stands at 0.26, indicating a preference for calls over puts among traders. Investors are likely gearing up for the upcoming earnings report anticipated on July 30th, as they position themselves for potential positive movements in the stock.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 19 analysts, the average target price for Teladoc Health Inc (TDOC, Financial) is $9.37 with a high estimate of $12.00 and a low estimate of $7.00. The average target implies an upside of 32.23% from the current price of $7.08. More detailed estimate data can be found on the Teladoc Health Inc (TDOC) Forecast page.
Based on the consensus recommendation from 26 brokerage firms, Teladoc Health Inc's (TDOC, Financial) average brokerage recommendation is currently 2.8, indicating "Hold" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Teladoc Health Inc (TDOC, Financial) in one year is $18.95, suggesting a upside of 167.47% from the current price of $7.0849. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Teladoc Health Inc (TDOC) Summary page.
TDOC Key Business Developments
Release Date: April 30, 2025
- Consolidated Revenue: $629.4 million, down 3% year-over-year.
- Adjusted EBITDA: $58.1 million, representing a margin of 9.2%.
- Net Loss Per Share: $0.53, including a noncash goodwill impairment charge of $0.34 per share pretax.
- Free Cash Flow: Net outflow of $16 million, an improvement of $11 million versus the prior year period.
- Cash and Cash Equivalents: Nearly $1.2 billion at quarter end.
- Integrated Care Segment Revenue: $389.5 million, increased 3.3% over the prior year period.
- U.S. Integrated Care Membership: 102.5 million members, up 12% year-over-year.
- U.S. Virtual Visit Volume: Increased by 7% year-over-year.
- Chronic Care Enrollment: 1.15 million, up approximately 3% year-over-year.
- BetterHelp Segment Revenue: $239.9 million, down 11% versus the prior year.
- BetterHelp Adjusted EBITDA: $7.7 million, with a margin of 3.2%.
- Full-Year 2025 Revenue Guidance: $2.047 billion to $2.058 billion.
- Full-Year 2025 Adjusted EBITDA Guidance: $263 million to $304 million.
- Second Quarter Revenue Guidance: $614 million to $633 million.
- Second Quarter Adjusted EBITDA Guidance: $56 million to $70 million.
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Positive Points
- Teladoc Health Inc (TDOC, Financial) reported revenues and adjusted EBITDA at the higher end of their first-quarter guidance ranges.
- The acquisition of Virtual Mental Health Company UpLift is expected to enhance the BetterHelp segment by providing access to over 100 million covered lives.
- The Integrated Care segment saw a significant milestone with U.S. membership surpassing 100 million, growing by 8.7 million members sequentially.
- International business continues to grow with mid-teens revenue growth on a constant currency basis, showcasing strong performance in both B2B and public health channels.
- Teladoc Health Inc (TDOC) was recognized as one of Newsweek's Most Trustworthy Companies in America for 2025, ranking number one in the healthcare and life sciences industry.
Negative Points
- First-quarter consolidated revenue was down 3% year-over-year, and the net loss per share increased compared to the previous year.
- The BetterHelp segment experienced an 11% decline in revenue compared to the prior year, with adjusted EBITDA margin decreasing from 5.7% to 3.2%.
- The company faces potential headwinds from tariffs, which could impact adjusted EBITDA by $5 million to $10 million in 2025.
- There was a slight uptick in churn rates for BetterHelp, indicating potential challenges in retaining users.
- The acquisition of UpLift is expected to lead to an incremental headwind of approximately $10 million to $15 million to 2025 adjusted EBITDA due to additional operational investments.
